Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Bellerophon Therapeutics Q2 EPS $(0.43) Down From $(0.36) YoY

Bellerophon Therapeutics Q2 EPS $(0.43) Down From $(0.36) YoY

Bellerophon Therapeutics (NASDAQ:BLPH) reported quarterly losses of $(0.43) per share. This is a 19.44 percent decrease over losses of $(0.36) per share from the same period last year.

byBenzinga Newsdesk

August 15, 2022

1 minute read

Bellerophon Therapeutics (NASDAQ:BLPH) reported quarterly losses of $(0.43) per share. This is a 19.44 percent decrease over losses of $(0.36) per share from the same period last year.

Earnings

Earnings Preview For Principal Finl Gr

By Benzinga Insights

July 26, 1:02 PM

Principal Finl Gr (NASDAQ:PFG) is set to give its latest quarterly earnings report on Thursday, 2023-07-27. Here’s what…

PFG

Why Sumo Logic Shares Are Soaring Higher Today

By Henry Khederian

December 6, 11:13 AM

Sumo Logic Inc (NASDAQ: SUMO) shares are trading higher by 15.53% to $8.33 Tuesday morning after the company reported better-than-expected third-quarter results and issued strong guidance. What Happened?

SUMO

Why Akoustis Technologies Stock Is Surging

By Erica Kollmann

May 22, 10:54 AM

Akoustis Technologies shares are trading higher Wednesday after the company reportedly floated the probability of bankruptcy after losing a lawsuit against Qorvo, Inc. and announced the final release to manufacturing of design updates across its product portfolio.

AKTS